Xlumena Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
16
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$80M
Xlumena General Information
Description
Developer of image-guided therapeutic endoscopy products. The company develops products that enable advanced image-guided endoscopy procedures to allow endoscopists to offer minimally invasive alternatives to patients suffering from common gastrointestinal and biliary conditions.
Contact Information
Website
www.xlumena.comCorporate Office
- 453 Ravendale Drive
- Suite H
- Mountain View, CA 94043
- United States
Corporate Office
- 453 Ravendale Drive
- Suite H
- Mountain View, CA 94043
- United States
Xlumena Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 02-Apr-2015 | $80M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series C) | 03-Dec-2013 | Completed | Startup | |||
| 4. Later Stage VC (Series B) | 04-Oct-2013 | Completed | Startup | |||
| 3. Early Stage VC (Series B) | 21-Aug-2012 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 28-Apr-2011 | $7M | $13.1M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 21-May-2008 | $6.15M | $6.15M | Completed | Startup |
Xlumena Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series B | 15,500,000 | $0.001000 | $0.04 | $0.62 | $0.62 | 1x | $0.62 | 13.85% |
| Series A | 19,991,930 | $0.001000 | $0.04 | $0.62 | $0.62 | 1x | $0.62 | 17.86% |
Xlumena Comparisons
Industry
Financing
Details
Xlumena Competitors (29)
One of Xlumena’s 29 competitors is Abiomed, a Corporate Backed or Acquired company based in Danvers, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abiomed | Corporate Backed or Acquired | Danvers, MA | ||||
| Insightec | Venture Capital-Backed | Tirat Carmel, Israel | ||||
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Morphic Medical | Private Equity-Backed | Boston, MA | ||||
| Endologix | Corporation | Santa Rosa, CA |
Xlumena Patents
Xlumena Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2946789-A1 | Biliary stent | Inactive | 18-Jun-2014 | ||
| WO-2015195893-A1 | Biliary stent | Inactive | 18-Jun-2014 | ||
| US-10722341-B2 | Biliary stents and methods | Active | 18-Jun-2014 | ||
| US-20160135941-A1 | Biliary stents and methods | Inactive | 18-Jun-2014 | ||
| US-20180289463-A1 | Biliary stents and methods | Active | 18-Jun-2014 | A61F2/04 |
Xlumena Signals
Xlumena Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ATEL Capital Group | Asset Manager | Minority | ||
| Aperture Venture Partners | Venture Capital | Minority | ||
| Ascent Biomedical Ventures | Venture Capital | Minority | ||
| Charter Life Sciences | Venture Capital | Minority | ||
| Prism Venture Management | Venture Capital | Minority |
Xlumena FAQs
-
When was Xlumena founded?
Xlumena was founded in 2008.
-
Where is Xlumena headquartered?
Xlumena is headquartered in Mountain View, CA.
-
What is the size of Xlumena?
Xlumena has 16 total employees.
-
What industry is Xlumena in?
Xlumena’s primary industry is Therapeutic Devices.
-
Is Xlumena a private or public company?
Xlumena is a Private company.
-
What is the current valuation of Xlumena?
The current valuation of Xlumena is .
-
What is Xlumena’s current revenue?
The current revenue for Xlumena is .
-
How much funding has Xlumena raised over time?
Xlumena has raised $50.1M.
-
Who are Xlumena’s investors?
ATEL Capital Group, Aperture Venture Partners, Ascent Biomedical Ventures, Charter Life Sciences, and Prism Venture Management are 5 of 7 investors who have invested in Xlumena.
-
Who are Xlumena’s competitors?
Abiomed, Insightec, Boston Scientific, Morphic Medical, and Endologix are some of the 29 competitors of Xlumena.
-
When was Xlumena acquired?
Xlumena was acquired on 02-Apr-2015.
-
Who acquired Xlumena?
Xlumena was acquired by Boston Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process